An Unusual Presentation of Prostate Adenocarcinoma Metastatic to the Oral Cavity  by Weng, Wen-Ching et al.
CASE REPORT
Urol Sci 2011;22(2):83−85
©2011 Taiwan Urological Association. Published by Elsevier Taiwan LLC. 83
An Unusual Presentation of Prostate Adenocarcinoma 
Metastatic to the Oral Cavity
Wen-Ching Weng1, Wei-Chou Lin2, Yeong-Shiau Pu1, Hong-Jeng Yu1, 
Chao-Yuan Huang1*
1Department of Urology, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei, Taiwan
2Department of Pathology, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei, Taiwan
The lymph nodes and bones are the most common sites of metastases in advanced 
prostate cancer. However, an unusual clinical presentation or one that mimics another 
entity may make diagnosis difficult. We report a male patient with metastatic prostate 
cancer who presented with a primarily localized buccal tumor. Prostatic origin was 
highly suspected only after positive results of prostate-specific antigen staining from 
biopsy pathology. We share our clinical experience and review the literature.
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1.  Introduction
The lymph nodes and bones are the most common sites 
of metastases in advanced prostate cancer. However, an 
unusual clinical presentation or one that mimics another 
entity can result in a difficult diagnosis. We report a male 
patient with metastatic prostate cancer who initially pre-
sented as a localized buccal tumor. Because buccal can-
cer is the fourth leading cancer of men in Taiwan, primary 
buccal cancer was impressed at first. Finally, buccal le-
sion biopsy showed adenocarcinoma with positive PSA, 
which confirmed the final diagnosis. Adequate immuno-
histochemical study was helpful and made the differen-
tial diagnosis clearly, from primary oral cavity cancer to 
prostate cancer metastasis.
Metastasis to the gingiva from prostatic adenocarci-
noma has been previously reported.4,5 However, buccal 
mucosa metastasis for a primary tumor is rare. We report 
here an unusual case and review the literature.
2.  Case Report
A 76-year-old Taiwanese man presented to our center with 
a 2-month history of a toothache and painful swelling of 
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Figure 1 Left buccal mucosal ulcerative mass after the biopsy 
(black arrows).
the left cheek. He did not smoke or chew betel nut. 
A physical examination revealed a shallow ulcerative 
mass with no bleeding (Figure 1), which was 3.5 × 1.5 cm, 
around the left premolar tooth. In addition, no signifi-
cant lymphadenopathy was found. Magnetic resonance 
imaging of the head and neck indicated a destructive 
bony lesion with prominent extraosseous soft tissue at 
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the left mandible (Figure 2). Therefore, a buccal tumor 
with extensive bony invasion was our first impression, 
and radical surgery was considered. However, the pa-
thology report from a simple biopsy indicated that it was 
an adenocarcinoma (Figure 3), which was strongly posi-
tive for prostate-specific antigen (PSA) and negative for 
both CK7 and CK20. Therefore, metastasis may have 
been the reason why this patient had positive PSA stain-
ing on buccal pathology. Radical surgery was delayed, 
and we searched for the primary source.
A tumor marker screening test showed high serum 
PSA levels (maximum, 168 ng/mL), and a stony-hard 
prostate was palpated. The pathology from transrectal 
ultrasound-guided prostatic biopsy revealed an adeno-
carcinoma with a Gleason score of 4 + 4. The clinical 
stage was cT3N0M1c. The patient underwent androgen 
deprivation therapy with maximal androgen blockage. 
The clinical response was good, and the buccal lesion al-
most completely healed. The most recent PSA measure-
ment was 0.252 ng/mL after 16 months of treatment.
3.  Discussion
Oral cavity tumors in Taiwan are a significant public issue 
mainly because of the local culture. A proportion of the 
residents habitually smoke cigarettes, consume alcohol, 
and chew betel nut, which are risk factors for oral cavity 
tumors.1,2 According to national statistics, oral cavity can-
cer, which is of great concern, became the sixth most com-
mon malignancy with a mortality rate of approximately 
7.8% in 2008 in Taiwan. In clinical practice, an oral cavity 
tumor in a patient is considered a primary malignancy. 
However, this was not the case in our patient. He presented 
with a toothache and an ulcerative buccal tumor, with the 
unusual pathology of an adenocarcinoma with positive PSA 
staining. Therefore, we withheld treatment of radical sur-
gery for a buccal tumor to define the primary source.
To our knowledge, advanced prostate cancer inevita-
bly progresses to metastasis even after aggressive treat-
ment. The axial skeleton is the most common site of 
distant metastases. That is why the stage workup for ad-
vanced prostate cancer should always include a radionu-
clide bone scan. However, metastatic lesions to the oral 
cavity from distant tumors are uncommon, accounting 
for only 1% of all oral malignancies,3–5 and they usually 
involve bony structures. Hirshberg et al. claimed that the 
oral cavity is an uncommon site for metastases and that 
histological diagnosis should be given for differentiating 
primary intraoral malignancies from metastatic tumors.6 
Although it is not common, cancers metastatic to the oral 
cavity have been reported, including cancers of lung, 
kidney, and liver in men and cancers of breast, genital 
organs in women.6 Our case had metastases to the soft 
tissue (buccal mucosa) and to bony structures at the initial 
presentation. The stage was cT3N0M1c.
Prostate cancer was the fifth most common cancer in 
men in 2007 and is the seventh leading cause of cancer 
death in men in Taiwan. However, only a few cases have 
been reported to have oral cavity metastases. Prostate 
cancer that metastasizes to the gingiva has been reported, 
but it may have been an extension of bone metastasis 
involving the jawbone. Immunohistochemistry for PSA 
is helpful in making a diagnosis. A thorough physical 
examination, including a digital rectal exam, should also 
be performed for male patients.
Metastatic prostate cancers respond relatively well to 
hormone therapy.7,8 The buccal tumor had resolved by 
the 8th month of complete androgen blockage therapy 
and no de novo lesions were noted after 16 months of 
follow-up.
4.  Conclusions
A common disease with an uncommon presentation is 
always a challenge. A diagnosis of prostate cancer initially 
from a metastatic site is not uncommon, and it may even 
metastasize to soft tissues in the oral cavity, mimicking 
Figure 2 Destructive bone lesions with prominent extraos-
seous soft tissue at the left mandible. It is indistinct from the 
adjacent masticator muscles (white arrows).
Figure 3 Immunohistochemically, tumor cells are strongly 
positive for prostate-specific antigen and negative for both 
CK7 and CK20 (original magnification, 100×).
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a different primary or benign disease. Therefore, it is im-
portant to consider prostate cancer as a possibility when 
an elderly man without typical risk factors of oral cancer 
presents with a buccal tumor as the chief complaint.
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